Is It Really Another UTI: Interstitial Cystitis and the Pharmacist's Role in Identifying the Patient At Risk
Paper Symposium
Activity Date: March 2005  — Activity Info: Volume 2, (1)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity


Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:


Candace S. Brown, PharmD
Professor of Pharmacy
University of Tennessee
College of Pharmacy
Memphis, Tennessee
Dr Brown reports receiving grants/research support from Forest Laboratories, Inc and
Procter & Gamble and serving as a consultant to Berlex, Inc and Procter & Gamble.


Jeffrey R. Dell, MD
Institute for Female Pelvic Medicine
Knoxville, Tennessee
Dr Dell reports serving as a consultant to Ortho-McNeil Pharmaceutical, Inc.
Robert J. Evans, MD
The Urology Center
Greensboro, North Carolina
Dr Evans reports serving as a consultant to Ortho-McNeil Pharmaceutical, Inc.

Mary Lee, PharmD, BCPS, FCCP
Dean and Professor
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
Dr Lee reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Notice: In accordance with the ACPE Criteria for Quality, the audience is advised that articles in this continuing pharmaceutical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Dr Dell—amitriptyline, gabapentin, gonadotrophin analogues, heparin sulfate, heparin with lidocaine and sodium bicarbonate buffer, hyaluronic acid, hycoscyamine sulfate, hydroxyzine hydrochloride, oral contraceptives, pentosan polysulfate sodium with lidocaine and sodium
bicarbonate buffer, tricyclic antidepressants.
Dr Lee—hydroxyzine hydrochloride, phenazopyridine, tricyclic antidepressants.

Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

Home | Contact Us | View Account | Need Help?